The Advanced RCC Prognostic Calculator is an easy-to-use resource, utilizing prognostic risk factors based on the published Memorial Sloan-Kettering Cancer Center (MSKCC) data (1) for advanced renal cell carcinoma (advanced RCC), and published expanded criteria, as adopted by the National Comprehensive Cancer Network (NCCN) Guidelines(TM) for Kidney Cancer.(2)
The tool provides a simple way to calculate prognostic risk for patients with advanced RCC. First, you select the prognostic risk factors you’d like to use. Then you enter values for 5 risk factors: Karnofsky performance status, time from diagnosis to initiation of systemic therapy, corrected serum Ca, LDH, and hemoglobin. If you choose the expanded criteria, you will also be asked to enter an additional value, for the number of sites of organ metastasis. The tool shows a prognostic risk classification based on the risk factors you choose and the values you enter.
ADVANCED RCC PROGNOSTIC CALCULATOR FEATURES
•Prognostic risk calculator for patients with advanced RCC
•Corrected Serum Calcium Calculator
•Karnofsky and ECOG performance indices
•RCC histology images, incidences, and genetic features
•Estimated survival based on published MSKCC data
You will not be required to enter any personally identifiable information about patients or yourself. This application is current as of its release. This application is not to be used as a substitute for medical judgment, advice, diagnosis, management, or treatment of any health condition or problem.
References:
1.Motzer RJ, Bacik J, Murphy BA, et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20:289-296.
2.National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer. V.2.2012.
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(TM)) for Kidney Cancer V.2.2012. (C) 2012 National Comprehensive Cancer Network, Inc. All rights reserved. The NCCN Guidelines(TM) may not be reproduced in any form for any purpose without the express written permission of the NCCN. To view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org (http://www.nccn.org/). NATIONAL COMPREHENSIVE CANCER NETWORK(R), NCCN(R), NCCN GUIDELINES(TM), and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.